[Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
D000243:Adenosine Deaminase / Q000172:deficiency / Q000235:genetics*; D018952:Antigens, CD34 / Q000378:metabolism; D002478:Cells, Cultured; D002648:Child; D041321:Chromosomes, Human, X; D002985:Clinical Protocols; D015316:Genetic Therapy / Q000379:methods; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000276:immunology / Q000378:metabolism; D006801:Humans; D016511:Severe Combined Immunodeficiency / Q000201:enzymology / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation; D014161:Transduction, Genetic; D014182:Transplantation, Autologous
D018952:Antigens, CD34; D000243:Adenosine Deaminase
Przeszczepianie genetycznie zmodyfikowanych komórek w leczeniu dzieci z ciezkim złozonym niedoborem odporności (SCID) -- wielkie nadzieje i rozczarowania.